Orin Hirschman 13D and 13G filings for Cellectar Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-27 10:07 am Sale |
2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Orin Hirschman | 67,407 4.900% |
-21,337 (-24.04%) |
Filing |
| 2024-02-07 6:58 pm Purchase |
2024-01-23 | 13G | Cellectar Biosciences, Inc. CLRB |
Orin Hirschman | 88,744 8.700% |
24,903 (+39.01%) |
Filing |
| 2023-12-05 06:01 am Purchase |
2023-11-07 | 13G | Cellectar Biosciences, Inc. CLRB |
Orin Hirschman | 63,841 9.900% |
63,841 (New Position) |
Filing |